REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Diabetes Solutions (Lithuania)

Main Activities: Software Publishers | Custom Computer Programming Services
Secondary Activities: Electronic Shopping and Mail-Order Houses
Full name: UAB Diabetes Solutions Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

UAB Diabetes Solutions is an enterprise located in Lithuania, with the main office in Vilnius. The company operates in the Software Publishers sector. The company was established on June 11, 2020. UAB Diabetes Solutions currently employs 21 (2025) people. The company’s latest financial report indicates a net sales revenue increase of 5.44% in 2023. The enterprise’s net profit margin increased by 18.68% in 2023.

Headquarters
Zalgirio g. 90-100
Vilnius; Vilnius county; Postal Code: LT-09303

Contact Details: Purchase the UAB Diabetes Solutions report to view the information.

Basic Information
Total Employees:
Purchase the UAB Diabetes Solutions report to view the information.
Registered Capital:
Purchase the UAB Diabetes Solutions report to view the information.
Financial Auditors:
Purchase the UAB Diabetes Solutions report to view the information.
Incorporation Date:
June 11, 2020
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Diabetes Solutions report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.44%
Total operating revenue
5.44%
Net Profit (Loss) for the Period
83.37%
Total Equity
-5.54%
Net Profit Margin
18.68%
Return on Equity (ROE)
-28.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?